Sponsors

Disease map

French genomics company IntegraGen has discovered a groundbreaking method of identifying causal disease genes, with the aid of Applied BiosystemsÆ custom assays and the SNPIex genotyping system.

Its gene-mapping technology û genome hybrid identity profiling (GenomeHIP) û works on the assumption that the same disease genes will be found in related individuals with the same disease, so the disease loci can be mapped by removing non-identical DNA sequences the genomes share. J÷rg Hager, IntegraGenÆs chief scientific officer, explained how Applied BiosystemsÆ products have helped: ôFor any disease in a given population, we identify up to seven potential disease loci, assemble a panel of region-specific SNPs and have assays manufactured by Applied Biosystems. Within a couple of days we can use the assays to analyse a large number of individuals using the SNPIex Genotyping System.ö

Latest Issues

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025

Annual SHOT Symposium

Hilton Birmingham Metropole Hotel, B40 1P
11 July 2025